TLR4 and serum lipopolysaccharide activity: By reducing lipopolysaccharides (LPS) translocation from gram-negative bacteria into the systemic circulation, PUFAs lower endotoxemia and the subsequent activation of toll-like receptor 4 (TLR4)-mediated inflammatory pathways implicated in metabolic disturbances.